238 related articles for article (PubMed ID: 26965957)
1. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.
Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B
J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957
[TBL] [Abstract][Full Text] [Related]
2. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat.
Kigasawa K; Kajimoto K; Hama S; Saito A; Kanamura K; Kogure K
Int J Pharm; 2010 Jan; 383(1-2):157-60. PubMed ID: 19732811
[TBL] [Abstract][Full Text] [Related]
4. Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes.
Chen Z; Zhang T; Wu B; Zhang X
Int J Nanomedicine; 2016; 11():991-1002. PubMed ID: 27042054
[TBL] [Abstract][Full Text] [Related]
5. Epidermal cell culture model with tight stratum corneum as a tool for dermal gene delivery studies.
Paasonen L; Korhonen M; Yliperttula M; Urtti A
Int J Pharm; 2006 Jan; 307(2):188-93. PubMed ID: 16297582
[TBL] [Abstract][Full Text] [Related]
6. Topical delivery of siRNA into skin using SPACE-peptide carriers.
Chen M; Zakrewsky M; Gupta V; Anselmo AC; Slee DH; Muraski JA; Mitragotri S
J Control Release; 2014 Apr; 179():33-41. PubMed ID: 24434423
[TBL] [Abstract][Full Text] [Related]
7. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array.
Haigh O; Depelsenaire AC; Meliga SC; Yukiko SR; McMillan NA; Frazer IH; Kendall MA
J Control Release; 2014 Nov; 194():148-56. PubMed ID: 25192942
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer.
Jose A; Labala S; Venuganti VV
J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148
[TBL] [Abstract][Full Text] [Related]
9. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.
Tran MA; Gowda R; Sharma A; Park EJ; Adair J; Kester M; Smith NB; Robertson GP
Cancer Res; 2008 Sep; 68(18):7638-49. PubMed ID: 18794153
[TBL] [Abstract][Full Text] [Related]
10. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
11. Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis.
Ibaraki H; Kanazawa T; Kurano T; Oogi C; Takashima Y; Seta Y
Biol Pharm Bull; 2019; 42(7):1216-1225. PubMed ID: 31257297
[TBL] [Abstract][Full Text] [Related]
12. An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis.
Desmet E; Bracke S; Forier K; Taevernier L; Stuart MC; De Spiegeleer B; Raemdonck K; Van Gele M; Lambert J
Int J Pharm; 2016 Mar; 500(1-2):268-74. PubMed ID: 26806466
[TBL] [Abstract][Full Text] [Related]
13. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
[TBL] [Abstract][Full Text] [Related]
14. Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer.
Hsu T; Mitragotri S
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15816-21. PubMed ID: 21903933
[TBL] [Abstract][Full Text] [Related]
15. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.
Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
Molecules; 2016 Sep; 21(10):. PubMed ID: 27669207
[TBL] [Abstract][Full Text] [Related]
16. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA.
Kawai M; Ibaraki H; Takashima Y; Kanazawa T; Okada H
Mol Pharm; 2021 Mar; 18(3):1038-1047. PubMed ID: 33395310
[TBL] [Abstract][Full Text] [Related]
17. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
[TBL] [Abstract][Full Text] [Related]
18. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment.
Ruan W; Zhai Y; Yu K; Wu C; Xu Y
Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273
[TBL] [Abstract][Full Text] [Related]
19. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV
Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin.
Lee WR; Shen SC; Zhuo RZ; Wang KC; Fang JY
Hum Gene Ther; 2009 Jun; 20(6):580-8. PubMed ID: 19239381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
